M&T Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

M&T Bank’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3	Closed	-$25K	–	1647
2020 Q2	$25K	Buy	+3	New	+$1.7K	﹤0.01%	1508
2020 Q1	–	Sell	-20	Closed	-$108K	–	1683
2019 Q4	$108K	Sell	20 -19	-49%	-$6.39K	﹤0.01%	1315
2019 Q3	$23K	Buy	+39	New	+$11.5K	﹤0.01%	1544
2017 Q2	–	Sell	-20	Closed	-$49K	–	1678
2017 Q1	$49K	Buy	+20	New	+$7.41K	﹤0.01%	1538

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

M&T Bank's REGN Position: Q1 2026 in Review

M&T Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 0.92% in Q1 2026, selling an estimated $45.2K and leaving 6,376 shares worth $4.93M. The position accounts for 0.02% of the portfolio, ranked #392.

M&T Bank first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $27.6M in Q1 2015. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

M&T Bank held 6,376 shares of Regeneron Pharmaceuticals worth $4.93M as of Q1 2026.
M&T Bank sold 59 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $45.2K.
Regeneron Pharmaceuticals made up 0.02% of M&T Bank's portfolio in Q1 2026, its #392 holding.
M&T Bank first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
M&T Bank's Regeneron Pharmaceuticals position peaked at $27.6M in Q1 2015.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.